TYRP1 and neoplasm: In addition, based on the Cat-B-cleavable peptide FRRG, Shim et al. designed a facile method for preparing the Cat-B-sensitive prodrug FRRG-DOX, which could release drugs with Cat-B-specific cleavage of prodrugs at the tumor site (Figure 5A) [108].